摘要:
A subject-matter of the invention are 1-(Phenyl)-3-[ω-(amino)-alkoxyimino]-alk-1-ene derivatives of general formula
wherein R₁ and R₂ independently each stands for hydrogen, halogen or a C₁₋₄ alkoxy group or together represent a 3,4-methylenedioxy group, R stands for C₁₋₈ alkyl, R₃ represents hydrogen, C₁₋₄ alkyl or hydroxy, R₄ and R₅ independently each represents hydrogen, a C₁₋₁₂ alkyl group, optionally substituted by hydroxy, or a C₂₋₁₂ alkenyl or C₃₋₆ cycloalkyl group, óóóor R₄ and R₅ together with the nitrogen atom to which they are attached form a 4- to 7-membered heterocyclic ring, optionally comprising an oxygen, sulfur or a further nitrogen atom, which latter optionally may carry a phenyl, benzyl or C₁₋₄ alkyl substituent óóóand A represents a valency bond or a -CH₂-group, as well as stereo and optically active isomers and their mixtures, acid-addition salts and quaternary ammonium derivatives thereof. Furthermore the invention is concerned with a process for preparing these compounds as well as medicaments containing them and the use of them for preparing medicaments, particularly having ulcus and gastric-acid-secretion inhibiting and anxiolytic effects.
摘要:
The subject-matter of the invention is the use of 2-[phenylmethylene]-1-[3'-(amino)-2'-(hydroxy)-propoxy-imino]-cyclohexane derviates of formula
wherein
R and R₁ independently mean hydrogen or halogen atom(s), R o stands for hydrogen or a C₁₋₄ alkoxy group, R₂ and R₃ independently represent hydrogen atom(s), straight and/or branched chain C₁₋₈ alkyl group(s), optionally substituted by a dimethylamino group, or C₂₋₆ alkenyl or C₃₋₇ cycloalkyl group(s) or R₂ and R₃ together with the nitrogen atom to which they are attached form a 6-membered heterocyclic group containing an additional nitrogen atom, which latter optionally may bear a phenyl group, optionally substituted by a C₁₋₄ alkoxy group, and their stereoisomers and optical isomers and mixtures thereof as well as pharmaceutically acceptable acid addition salts and quaternary ammonium derivatives thereof, optionally in admixture with 1 or more carrier(s) commonly used in pharmaceutical compositions, for preparing medicaments having gastroprotective and antimicrobial including antiulcer activity.
摘要:
A subject-matter of the invention are oxaindene derivatives of general formula wherein
R 1 represents a C 1-4 -alkyl, C 1-4 -alkoxy or C 3-6 -cycloalkyl group, R 2 stands for hydrogen or a C 1-4 -alkyl or C 3-6 -cycloalkyl group, R 3 represents hydrogen or a C 1-4 -alkyl, C 1-4 -alkoxy or benzyloxy group, X means hydrogen, an aliphatic C 1-4 -acyl or benzoyl or naphthoyl group, optionally substituted by 1 or more nitro or C 1-4 -alkoxy group(s) or a group of formula in which latter R 7 stands for a C 1-4 -alkylene group and R 5 and R 6 each represents a C 1-4 -alkyl group or R 5 and R 6 together with the nitrogen atom to which they are attached form a piperidyl or morpholinyl group, A and B together form an ethylene or a vinylene group and n is 1, 2 or 3, and their stereoisomers and their mixtures as well as acid addition salts of these compounds. Moreover there are provided for a process for preparing these compounds, medicaments containing them and the use of these compounds. They have a strong 5-lipoxygenase enzyme inhibiting activity.
摘要:
A subject-matter of the invention are 1-[styryl]- and 1-[2'-(heteroaryl)-ethenyl]-isoquinoline derivatives having the formula
wherein
n is 1, 2, 3 or 4, R which represent(s) hydrogen, C₁₋₇-alkyl, C₁₋₇-alkoxy or hydroxy, or two substituents R form together a C₁₋₇-alkylenedioxy group attached to two adjacent ring carbon atoms, R₁ represents hydrogen or C₁₋₇-alkyl and Ar stands for an aryl or heteroaryl group containing one or two oxygen, nitrogen and/or sulfur atom(s), optionally carrying one or more substituent(s) selected from halogen, trihalomethyl, hydroxy, C₁₋₇-alkyl, C₁₋₇-alkoxy, C₁₋₇-alkylenedioxy (attached to two adjacent ring carbon atoms), cyano, nitro, amino, mono- and di-(C₁₋₇-alkyl)-amino, as well as acid addition salts thereof. Furthermore the invention is concerned with a process for preparing these compounds as well as medicaments containing them and the use both of the novel and of the known compounds for preparing medicaments having an anxiolytic effect.
摘要:
A subject-matter of the invention are 1-(Phenyl)-3-[ω-(amino)-alkoxyimino]-alk-1-ene derivatives of general formula
wherein
R₁ and R₂ independently each stands for hydrogen, halogen or a C₁₋₄ alkoxy group or together represent a 3,4-methylenedioxy group, R stands for C₁₋₈ alkyl, R₃ represents hydrogen, C₁₋₄ alkyl or hydroxy, R₄ and R₅ independently each represents hydrogen, a C₁₋₁₂ alkyl group, optionally substituted by hydroxy, or a C₂₋₁₂ alkenyl or C₃₋₆ cycloalkyl group, óóóor R₄ and R₅ together with the nitrogen atom to which they are attached form a 4- to 7-membered heterocyclic ring, optionally comprising an oxygen, sulfur or a further nitrogen atom, which latter optionally may carry a phenyl, benzyl or C₁₋₄ alkyl substituent óóóand A represents a valency bond or a -CH₂-group, as well as stereo and optically active isomers and their mixtures, acid-addition salts and quaternary ammonium derivatives thereof. Furthermore the invention is concerned with a process for preparing these compounds as well as medicaments containing them and the use of them for preparing medicaments, particularly having ulcus and gastric-acid-secretion inhibiting and anxiolytic effects.
摘要:
The subject matter of the invention is the use of [a] bicycloheptane derivative(s) of formula
wherein
R represents a phenyl or a benzyl group, R₁ and R₂ , which may be the same or different stand for straight or branched chained alkyl groups or one of R₁ and R₂ is hydrogen and the other is a straight or branched chained alkyl group, A denotes a straight or branched chained alkylene group and ∼ represents a valence bond, and [an] N-oxide(s) as well as [an] optical isomer(s) thereof and mixtures of the optical isomers and [an] acid addition salt(s) and quaternary ammonium derivative(s) of the bicycloheptane derivatives of formula I as well as [an] optical isomer(s) thereof and mixtures of the optical isomers for preparing medicaments for the treatment of diseases and disorders which are connected with the influence on the peripheral cholecystokinin (CCK) system.